Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
- 1 July 1996
- journal article
- Published by Elsevier in The Lancet
- Vol. 348 (9019), 17-24
- https://doi.org/10.1016/s0140-6736(96)02166-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Testing for Antibody to Human Immunodeficiency Virus Type 1 in a Population in which Mycobacterial Diseases Are EndemicThe Journal of Infectious Diseases, 1995
- A re-examination of the variations in the efficacy of BCG vaccination against tuberculosis in clinical trialsTubercle and Lung Disease, 1994
- Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-AnalysisInternational Journal of Epidemiology, 1993
- The safety of Bacille Calmette—Guérin vaccination in HIV infection and AIDSAIDS, 1993
- Influence of Tuberculosis on Human Immunodeficiency Virus (HIV-1): Enhanced Cytokine Expression and Elevated 2-Microglobulin in HIV-1-Associated TuberculosisThe Journal of Infectious Diseases, 1993
- Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago, ChileTubercle and Lung Disease, 1992
- Efficacy of BCG vaccine against leprosy and tuberculosis in northern MalawiThe Lancet, 1992
- Immunoprophylactic trial with combined Mycobacterium Leprae/BCG vaccine against leprosy: preliminary resultsThe Lancet, 1992
- Hypersensitivity to dextran in BCG vaccineThe Lancet, 1991
- BCG vaccination of children against leprosy in Uganda: final resultsEpidemiology and Infection, 1981